Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
1401
Under steatotic conditions, primary <i>mMgat2</i> and <i>HuMgat2</i> hepatocytes induce apoptosis.
Published 2025Subjects: -
1402
-
1403
Obese <i>mMgat2</i> and <i>HuMgat2</i> mice show defects in solute transporter protein levels.
Published 2025Subjects: -
1404
-
1405
Obese <i>mMgat2</i> and <i>HuMgat2</i> mice develop MASLD and fibrosis on an HFD.
Published 2025Subjects: -
1406
GRADE judgements.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1407
Basic characteristics of the included studies.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1408
The data of meta-analysis.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1409
Risk of bias.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1410
Overall risk of bias assessment.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1411
Funnel plot of VO<sub>2Peak</sub> inclusion studies.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1412
Analysis of subgroups.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
1413
-
1414
-
1415
-
1416
Baseline sociodemographic data and disease-related variables of two groups (n = 105).
Published 2025Subjects: -
1417
-
1418
-
1419
-
1420